The FDA approves the first treatment for a human illness

The US Food and Drug Administration (FDA) has approved two gene therapy drugs for sickle cell disease, a blood disorder where red blood cells carry oxygen through the body, to be used as treatments. One of the therapies is called ‘Casgevy’ and it uses removing cells from each patient’s bone marrow, editing a gene and then returning billions of the modified cells to patients.